Calithera Biosciences IncMost RecentEarnings ReportHow Bristol-Myers Squibb’s Oncology Drug Performed in 4Q16Bristol-Myers Squibb’s (BMY) latest drug, Opdivo, was the seventh drug to be approved by the FDA for the treatment of melanoma.
Earnings ReportHow Bristol-Myers Squibb’s Oncology Drug Performed in 4Q16Bristol-Myers Squibb’s (BMY) latest drug, Opdivo, was the seventh drug to be approved by the FDA for the treatment of melanoma.
